<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://wiki.jackslab.org/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="zh-cn">
		<id>http://wiki.jackslab.org/index.php?action=history&amp;feed=atom&amp;title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89</id>
		<title>犬心包积液的超声心动图和临床病理学特征：107 例 （1985–2006） - 版本历史</title>
		<link rel="self" type="application/atom+xml" href="http://wiki.jackslab.org/index.php?action=history&amp;feed=atom&amp;title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89"/>
		<link rel="alternate" type="text/html" href="http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;action=history"/>
		<updated>2026-09-11T05:33:24Z</updated>
		<subtitle>本wiki的该页面的版本历史</subtitle>
		<generator>MediaWiki 1.19.2</generator>

	<entry>
		<id>http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17163&amp;oldid=prev</id>
		<title>2024年7月13日 (六) 01:20 Comcat</title>
		<link rel="alternate" type="text/html" href="http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17163&amp;oldid=prev"/>
				<updated>2024-07-13T01:20:56Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class='diff diff-contentalign-left'&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
			&lt;tr valign='top'&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←上一版本&lt;/td&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;2024年7月13日 (六) 01:20的版本&lt;/td&gt;
			&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第2行：&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第2行：&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;原文：https://sci.bban.top/pdf/10.2460/javma.235.12.1456.pdf&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;原文：https://sci.bban.top/pdf/10.2460/javma.235.12.1456.pdf&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Published: 2009&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== 摘要 ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== 摘要 ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Comcat</name></author>	</entry>

	<entry>
		<id>http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17162&amp;oldid=prev</id>
		<title>2024年7月13日 (六) 01:20 Comcat</title>
		<link rel="alternate" type="text/html" href="http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17162&amp;oldid=prev"/>
				<updated>2024-07-13T01:20:27Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class='diff diff-contentalign-left'&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
			&lt;tr valign='top'&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←上一版本&lt;/td&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;2024年7月13日 (六) 01:20的版本&lt;/td&gt;
			&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第1行：&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第1行：&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Echocardiographic and clinicopathologic characterization of pericardial effusion in dogs: 107 cases (1985–2006)&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Echocardiographic and clinicopathologic characterization of pericardial effusion in dogs: 107 cases (1985–2006)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;原文：https://sci.bban.top/pdf/10.2460/javma.235.12.1456.pdf&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== 摘要 ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== 摘要 ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Comcat</name></author>	</entry>

	<entry>
		<id>http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17120&amp;oldid=prev</id>
		<title>Comcat：/* 结论 */</title>
		<link rel="alternate" type="text/html" href="http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17120&amp;oldid=prev"/>
				<updated>2024-07-12T02:33:33Z</updated>
		
		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;结论&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class='diff diff-contentalign-left'&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
			&lt;tr valign='top'&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←上一版本&lt;/td&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;2024年7月12日 (五) 02:33的版本&lt;/td&gt;
			&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第128行：&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第128行：&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;血液学和血清生化分析结果可用于 90 只心包积液犬的审查。'''贫血'''是检测到的最常见的异常（23/90 [25.6%] 犬）。所有狗的贫血均为轻度（PCV，30%-37%）、色素正常、细胞正常且不可再生，但 2 只狗的 PCV &amp;lt; 30% 除外。在任何狗中均未检测到形态学红细胞异常。贫血最常见于患有血管肉瘤 （n = 8 只狗）、心包炎 （6） 和间皮瘤 （4） 的狗。90 只狗中有 21 只 （23.3%） 检测到肝酶活性增加；这些增长都被认为是温和的。在患有血管肉瘤 （n = 9）、化学感受器瘤 （5）、心包炎 （4）、不明确的心脏基底肿块 （2） 和甲状腺腺癌 （1） 的狗中'''检测到肝酶的高活性'''。血'''小板减少'''症（&amp;lt; 200,000 个血小板/μL）是第三大最常见的实验室异常，在 90 只狗中有 12 只 （13.3%） 发现。在患有血管肉瘤 （n = 6）、心包炎 （4） 和淋巴肉瘤 （2） 的狗中检测到血小板减少症。其他不常见的异常包括轻度氮质血症（4/90 只狗），凝血酶原时间、部分凝血活酶时间或两者轻微延长 （3），轻度高钙血症（3），和轻度高钾血症 &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;（2）。在&lt;/del&gt;'''&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;具有 3 种最常检测到的血液学或生化异常（贫血、肝酶活性高或血小板减少症）的狗中，心包积液的最常见原因是血管肉瘤&lt;/del&gt;'''。&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;血液学和血清生化分析结果可用于 90 只心包积液犬的审查。'''贫血'''是检测到的最常见的异常（23/90 [25.6%] 犬）。所有狗的贫血均为轻度（PCV，30%-37%）、色素正常、细胞正常且不可再生，但 2 只狗的 PCV &amp;lt; 30% 除外。在任何狗中均未检测到形态学红细胞异常。贫血最常见于患有血管肉瘤 （n = 8 只狗）、心包炎 （6） 和间皮瘤 （4） 的狗。90 只狗中有 21 只 （23.3%） 检测到肝酶活性增加；这些增长都被认为是温和的。在患有血管肉瘤 （n = 9）、化学感受器瘤 （5）、心包炎 （4）、不明确的心脏基底肿块 （2） 和甲状腺腺癌 （1） 的狗中'''检测到肝酶的高活性'''。血'''小板减少'''症（&amp;lt; 200,000 个血小板/μL）是第三大最常见的实验室异常，在 90 只狗中有 12 只 （13.3%） 发现。在患有血管肉瘤 （n = 6）、心包炎 （4） 和淋巴肉瘤 （2） 的狗中检测到血小板减少症。其他不常见的异常包括轻度氮质血症（4/90 只狗），凝血酶原时间、部分凝血活酶时间或两者轻微延长 （3），轻度高钙血症（3），和轻度高钾血症 &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;（2）。在具有 3 种最常检测到的血液学或生化异常（&lt;/ins&gt;'''&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;贫血、肝酶活性高或血小板减少症'''）的狗中，心包积液的'''最常见原因是血管肉瘤&lt;/ins&gt;'''。&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Results of hematologic and serum biochemical analysis were available for review in 90 dogs with pericardial effusion. Anemia was the most common abnormality detected (23/90 [25.6%] dogs). Anemia was mild (PCV, 30% to 37%), normochromic, normocytic, and nonregenerative in all dogs, except for 2 in which the PCV was &amp;lt; 30%. Morphological RBC abnormalities were not detected in any of the dogs. Anemia was most commonly detected in dogs with hemangiosarcoma (n = 8 dogs), pericarditis (6), and mesothelioma (4). Increases in activities of liver enzymes were detected in 21 of 90 (23.3%) dogs; those increases were all considered mild. High activities of liver enzymes were detected in dogs with hemangiosarcoma (n = 9), chemodectoma (5), pericarditis (4), nondefined heart base masses (2), and thyroid gland adenocarcinoma (1). Thrombocytopenia (&amp;lt; 200,000 platelets/μL) was the third most common laboratory abnormality evident and was found in 12 of 90 (13.3%) dogs. Thrombocytopenia was detected in dogs with hemangiosarcoma (n = 6), pericarditis (4), and lymphosarcoma (2). Other uncommon abnormalities included mild azotemia (4/90 dogs); slight prolongation of the prothrombin time, partial thromboplastin time, or both (3); mild hypercalcemia (3); and mild hyperkalemia (2). In dogs with the 3 most commonly detected hematologic or biochemical abnormalities (anemia, high activities of liver enzymes, or thrombocytopenia), the most common cause of pericardial effusion was hemangiosarcoma.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Results of hematologic and serum biochemical analysis were available for review in 90 dogs with pericardial effusion. Anemia was the most common abnormality detected (23/90 [25.6%] dogs). Anemia was mild (PCV, 30% to 37%), normochromic, normocytic, and nonregenerative in all dogs, except for 2 in which the PCV was &amp;lt; 30%. Morphological RBC abnormalities were not detected in any of the dogs. Anemia was most commonly detected in dogs with hemangiosarcoma (n = 8 dogs), pericarditis (6), and mesothelioma (4). Increases in activities of liver enzymes were detected in 21 of 90 (23.3%) dogs; those increases were all considered mild. High activities of liver enzymes were detected in dogs with hemangiosarcoma (n = 9), chemodectoma (5), pericarditis (4), nondefined heart base masses (2), and thyroid gland adenocarcinoma (1). Thrombocytopenia (&amp;lt; 200,000 platelets/μL) was the third most common laboratory abnormality evident and was found in 12 of 90 (13.3%) dogs. Thrombocytopenia was detected in dogs with hemangiosarcoma (n = 6), pericarditis (4), and lymphosarcoma (2). Other uncommon abnormalities included mild azotemia (4/90 dogs); slight prolongation of the prothrombin time, partial thromboplastin time, or both (3); mild hypercalcemia (3); and mild hyperkalemia (2). In dogs with the 3 most commonly detected hematologic or biochemical abnormalities (anemia, high activities of liver enzymes, or thrombocytopenia), the most common cause of pericardial effusion was hemangiosarcoma.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;通过将各组分为 2 个时间段（1985 年至 1995 年的 42 只狗和 1996 年至 2006 年的 65 只狗）来评估心包积液原因分布的变化。所有 5 只患有感染性心包炎的狗都在第一个时间段内被发现，而 42 只 （14.3%） 患有特发性心包炎的狗中有 6 只在第一个时间段内被发现，65 只 （23.1%） 犬中有 15 只（23.1%）在第二个时间段内被发现。患有间皮瘤的狗的比例从第一个时间段的 3/42 只狗 （7.1%） 增加到第二个时间段的 12/65 狗 （18.5%）。相比之下，第一个时间段的 42 只狗中有 6 只 （14.3%） 患有化疗瘤，而第二个时间段的 65 只狗中只有 3 只 （4.6%）。在两个时间段之间，所有其他原因的比例相似。在 2 因素数据列联表上使用 Fisher 精确检验显示，间皮瘤 （P = 0.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;09）、化疗瘤 &lt;/del&gt;（P = 0.15） 或特发性心包炎 （P = 0.32） 的诊断频率在两个时间段之间没有显着差异。为了评估由于超声机的时间和空间分辨率的提高，在后期心脏肿块的诊断是否有所改善，比较了两个时间段之间使用超声心动图无法识别肿块的狗的数量。早期（5/42 [11.9%] 犬未发现肿块）与后期（7/65 [10.8%]犬未发现肿块）的百分比没有差异。&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;通过将各组分为 2 个时间段（1985 年至 1995 年的 42 只狗和 1996 年至 2006 年的 65 只狗）来评估心包积液原因分布的变化。所有 5 只患有感染性心包炎的狗都在第一个时间段内被发现，而 42 只 （14.3%） 患有特发性心包炎的狗中有 6 只在第一个时间段内被发现，65 只 （23.1%） 犬中有 15 只（23.1%）在第二个时间段内被发现。患有间皮瘤的狗的比例从第一个时间段的 3/42 只狗 （7.1%） 增加到第二个时间段的 12/65 狗 （18.5%）。相比之下，第一个时间段的 42 只狗中有 6 只 （14.3%） 患有化疗瘤，而第二个时间段的 65 只狗中只有 3 只 （4.6%）。在两个时间段之间，所有其他原因的比例相似。在 2 因素数据列联表上使用 Fisher 精确检验显示，间皮瘤 （P = 0.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;09）、化学感受器瘤 &lt;/ins&gt;（P = 0.15） 或特发性心包炎 （P = 0.32） 的诊断频率在两个时间段之间没有显着差异。为了评估由于超声机的时间和空间分辨率的提高，在后期心脏肿块的诊断是否有所改善，比较了两个时间段之间使用超声心动图无法识别肿块的狗的数量。早期（5/42 [11.9%] 犬未发现肿块）与后期（7/65 [10.8%]犬未发现肿块）的百分比没有差异。&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Changes in distribution of causes of pericardial effusion were evaluated by separating the groups into 2 time periods (42 dogs from 1985 through 1995 and 65 dogs from 1996 through 2006). All 5 dogs with infective pericarditis were identified in the first time period, whereas 6 of 42 (14.3%) dogs with idiopathic pericarditis were identified in the first time period and 15 of 65 (23.1%) dogs with idiopathic pericarditis were identified in the second time period. The proportion of dogs with mesothelioma increased from 3 of 42 (7.1%) dogs in the first time period to 12 of 65 (18.5%) dogs in the second time period. In contrast, 6 of 42 (14.3%) dogs in the first time period had chemodectomas, compared with only 3 of 65 (4.6%) dogs in the second time period. The proportions for all other causes were similar between the 2 time periods. Use of the Fisher exact test on a 2-way data contingency table revealed no significant difference in frequency of diagnosis of mesothelioma (P = 0.09), chemodectoma (P = 0.15), or idiopathic pericarditis (P = 0.32) between the 2 time periods. To assess whether there was improvement in diagnosis of cardiac masses in the later time period as a result of improvements in temporal and spatial resolution of ultrasound machines, the number of dogs in which use of echocardiography did not identify the mass was compared between the 2 time periods. There was no difference in the percentage of masses that were not identified between the early period (masses not identified in 5/42 [11.9%] dogs), compared with the percentage for the later period (masses not identified in 7/65 [10.8%] dogs).&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Changes in distribution of causes of pericardial effusion were evaluated by separating the groups into 2 time periods (42 dogs from 1985 through 1995 and 65 dogs from 1996 through 2006). All 5 dogs with infective pericarditis were identified in the first time period, whereas 6 of 42 (14.3%) dogs with idiopathic pericarditis were identified in the first time period and 15 of 65 (23.1%) dogs with idiopathic pericarditis were identified in the second time period. The proportion of dogs with mesothelioma increased from 3 of 42 (7.1%) dogs in the first time period to 12 of 65 (18.5%) dogs in the second time period. In contrast, 6 of 42 (14.3%) dogs in the first time period had chemodectomas, compared with only 3 of 65 (4.6%) dogs in the second time period. The proportions for all other causes were similar between the 2 time periods. Use of the Fisher exact test on a 2-way data contingency table revealed no significant difference in frequency of diagnosis of mesothelioma (P = 0.09), chemodectoma (P = 0.15), or idiopathic pericarditis (P = 0.32) between the 2 time periods. To assess whether there was improvement in diagnosis of cardiac masses in the later time period as a result of improvements in temporal and spatial resolution of ultrasound machines, the number of dogs in which use of echocardiography did not identify the mass was compared between the 2 time periods. There was no difference in the percentage of masses that were not identified between the early period (masses not identified in 5/42 [11.9%] dogs), compared with the percentage for the later period (masses not identified in 7/65 [10.8%] dogs).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;根据超声心动图分类，无心脏肿块的狗的寿命（P &amp;lt; 0.001）明显长（中位生存时间，10.10个月）比有心脏肿块超声心动图证据的狗（中位生存时间，0.53个月;图1）。通过使用超声心动图诊断为心脏基础肿块的狗&amp;lt;寿命显着长（P&amp;#160; 0.001）（中位生存时间，5.17个月）比使用超声心动图诊断为右心房肿块的狗（中位生存时间，0.03个月）。所有记录在案的死亡都是心包积液的特定原因的结果，而不是其他全身性疾病的结果。关于心包积液的具体原因，非肿瘤性病因的狗的寿命（P &amp;lt; 0.001）明显长于肿瘤病因的狗（中位生存时间，0.63个月），比肿瘤病因的狗（中位生存时间，0.63个月）长（P&amp;#160; 0.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;001）。患有血管肉瘤的狗的中位生存时间（0&lt;/del&gt;.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;07个月）明显（P &lt;/del&gt;&amp;lt; 0.001）比所有其他肿瘤原因的狗（5.17个月）短。患有间皮瘤的狗的中位生存时间（6.50 个月）与患有心脏基底肿块的狗的中位生存时间（P = 0.51）没有显着差异，包括趋化瘤、异位甲状腺组织或非特异性原因（5.17 个月）。&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;根据超声心动图分类，无心脏肿块的狗的寿命（P &amp;lt; 0.001）明显长（中位生存时间，10.10个月）比有心脏肿块超声心动图证据的狗（中位生存时间，0.53个月;图1）。通过使用超声心动图诊断为心脏基础肿块的狗&amp;lt;寿命显着长（P&amp;#160; 0.001）（中位生存时间，5.17个月）比使用超声心动图诊断为右心房肿块的狗（中位生存时间，0.03个月）。所有记录在案的死亡都是心包积液的特定原因的结果，而不是其他全身性疾病的结果。关于心包积液的具体原因，非肿瘤性病因的狗的寿命（P &amp;lt; 0.001）明显长于肿瘤病因的狗（中位生存时间，0.63个月），比肿瘤病因的狗（中位生存时间，0.63个月）长（P&amp;#160; 0.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;001）。'''患有血管肉瘤的狗的中位生存时间（0&lt;/ins&gt;.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;07个月）'''明显（P &lt;/ins&gt;&amp;lt; 0.001）比所有其他肿瘤原因的狗（5.17个月）短。患有间皮瘤的狗的中位生存时间（6.50 个月）与患有心脏基底肿块的狗的中位生存时间（P = 0.51）没有显着差异，包括趋化瘤、异位甲状腺组织或非特异性原因（5.17 个月）。&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;On the basis of echocardiographic classification, dogs with no cardiac mass lived significantly (P &amp;lt; 0.001) longer (median survival time, 10.10 months) than did dogs with echocardiographic evidence of a cardiac mass (median survival time, 0.53 months; Figure 1). Dogs with a heart base mass diagnosed by use of echocardiography lived significantly (P &amp;lt; 0.001) longer (median survival time, 5.17 months) than did dogs with a right atrial mass diagnosed by use of echocardiography (median survival time, 0.03 months). All deaths recorded were the result of the specific cause of the pericardial effusion and not the result of other systemic disease. Regarding specific causes of pericardial effusion, dogs with nonneoplastic causes lived significantly (P &amp;lt; 0.001) longer (median survival time, 24.83 months) than did dogs with neoplastic causes (median survival time, 0.63 months). Dogs with hemangiosarcoma had a significantly (P &amp;lt; 0.001) shorter median survival time (0.07 months) than did dogs with all other neoplastic causes combined (5.17 months). Median survival time of dogs with mesothelioma (6.50 months) did not differ significantly (P = 0.51) from that of dogs with heart base masses, which included chemodectoma, ectopic thyroid gland tissue, or nonspecific causes (5.17 months).&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;On the basis of echocardiographic classification, dogs with no cardiac mass lived significantly (P &amp;lt; 0.001) longer (median survival time, 10.10 months) than did dogs with echocardiographic evidence of a cardiac mass (median survival time, 0.53 months; Figure 1). Dogs with a heart base mass diagnosed by use of echocardiography lived significantly (P &amp;lt; 0.001) longer (median survival time, 5.17 months) than did dogs with a right atrial mass diagnosed by use of echocardiography (median survival time, 0.03 months). All deaths recorded were the result of the specific cause of the pericardial effusion and not the result of other systemic disease. Regarding specific causes of pericardial effusion, dogs with nonneoplastic causes lived significantly (P &amp;lt; 0.001) longer (median survival time, 24.83 months) than did dogs with neoplastic causes (median survival time, 0.63 months). Dogs with hemangiosarcoma had a significantly (P &amp;lt; 0.001) shorter median survival time (0.07 months) than did dogs with all other neoplastic causes combined (5.17 months). Median survival time of dogs with mesothelioma (6.50 months) did not differ significantly (P = 0.51) from that of dogs with heart base masses, which included chemodectoma, ectopic thyroid gland tissue, or nonspecific causes (5.17 months).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第144行：&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第144行：&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[文件:ECG.Fig1.jpg]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[文件:ECG.Fig1.jpg]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;图 1：由各种原因引起的心包积液狗的 Kaplan-Meier &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;生存曲线。A—有心包积液且无心脏肿块超声心动图证据的狗（方块）比有心脏肿块超声心动图证据的狗（圆圈）存活时间明显长（P &lt;/del&gt;&amp;lt; 0.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;001）。B—通过使用超声心动图（方块）诊断为心脏基础肿块的狗比使用超声心动图诊断为右心房肿块的狗（圆圈）存活时间明显长 &lt;/del&gt;（P = 0.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;002）。C—非肿瘤性心包积液原因的狗（根据组织学检查确定&lt;/del&gt;;方块）比有肿瘤性心包积液原因的狗存活时间明显长（P &amp;lt; 0.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;001）（圆圈）。D—患有血管肉瘤的狗（根据组织学检查确定&lt;/del&gt;;圆圈）的中位生存时间明显（P &amp;lt; 0.001）比所有其他肿瘤原因的狗加起来（平方）短。请注意，x 轴的刻度因面板而异。&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;图 1：由各种原因引起的心包积液狗的 Kaplan-Meier &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;生存曲线。A：有心包积液且无心脏肿块超声心动图证据的狗（方块）比有心脏肿块超声心动图证据的狗（圆圈）存活时间明显长（P &lt;/ins&gt;&amp;lt; 0.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;001）。B：通过使用超声心动图（方块）诊断为心脏基础肿块的狗比使用超声心动图诊断为右心房肿块的狗（圆圈）存活时间明显长 &lt;/ins&gt;（P = 0.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;002）。C：非肿瘤性心包积液原因的狗（根据组织学检查确定&lt;/ins&gt;;方块）比有肿瘤性心包积液原因的狗存活时间明显长（P &amp;lt; 0.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;001）（圆圈）。D：患有血管肉瘤的狗（根据组织学检查确定&lt;/ins&gt;;圆圈）的中位生存时间明显（P &amp;lt; 0.001）比所有其他肿瘤原因的狗加起来（平方）短。请注意，x 轴的刻度因面板而异。&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Figure 1: Kaplan-Meier survival curves for dogs with pericardial effusion attributable to various causes. A—Dogs with pericardial effusion and no echocardiographic evidence of a cardiac mass (squares) survived significantly (P &amp;lt; 0.001) longer than did dogs with echocardiographic evidence of a cardiac mass (circles). B—Dogs with a heart base mass diagnosed by use of echocardiography (squares) survived significantly (P = 0.002) longer than did dogs with a right atrial mass diagnosed by use of echocardiography (circles). C—Dogs with a nonneoplastic cause of pericardial effusion (as determined on the basis of histologic examination; squares) survived significantly (P &amp;lt; 0.001) longer than did dogs with a neoplastic cause of pericardial effusion (circles). D—Dogs with hemangiosarcoma (as determined on the basis of histologic examination; circles) had a significantly (P &amp;lt; 0.001) shorter median survival time than did dogs with all other neoplastic causes combined (squares). Notice that the scale for the x-axis differs among panels.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Figure 1: Kaplan-Meier survival curves for dogs with pericardial effusion attributable to various causes. A—Dogs with pericardial effusion and no echocardiographic evidence of a cardiac mass (squares) survived significantly (P &amp;lt; 0.001) longer than did dogs with echocardiographic evidence of a cardiac mass (circles). B—Dogs with a heart base mass diagnosed by use of echocardiography (squares) survived significantly (P = 0.002) longer than did dogs with a right atrial mass diagnosed by use of echocardiography (circles). C—Dogs with a nonneoplastic cause of pericardial effusion (as determined on the basis of histologic examination; squares) survived significantly (P &amp;lt; 0.001) longer than did dogs with a neoplastic cause of pericardial effusion (circles). D—Dogs with hemangiosarcoma (as determined on the basis of histologic examination; circles) had a significantly (P &amp;lt; 0.001) shorter median survival time than did dogs with all other neoplastic causes combined (squares). Notice that the scale for the x-axis differs among panels.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Comcat</name></author>	</entry>

	<entry>
		<id>http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17119&amp;oldid=prev</id>
		<title>Comcat：/* 结论 */</title>
		<link rel="alternate" type="text/html" href="http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17119&amp;oldid=prev"/>
				<updated>2024-07-12T02:28:05Z</updated>
		
		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;结论&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class='diff diff-contentalign-left'&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
			&lt;tr valign='top'&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←上一版本&lt;/td&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;2024年7月12日 (五) 02:28的版本&lt;/td&gt;
			&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第88行：&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第88行：&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;肿瘤是大多数 （76/107 [71%]） 狗心包积液的原因。15 只患有间皮瘤的狗中有 5 只患有离散的心脏肿块，最常见的是心脏底部 （4/5），很少是右心房 （1/5）。大多数 （35/40 [88%]） 右心房肿块为血管肉瘤，其次是神经内分泌肿瘤、甲状腺腺癌、间皮瘤、淋巴瘤和肉瘤各 1 例 （3%）。心脏基底肿块最常见的是神经内分泌肿瘤（9/23 [39.1%]狗），其次是甲状腺腺癌（6/23 [26.1%]）、间皮瘤（5/23 [21.7%]）和血管肉瘤（3/23 [13%]&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;）。间皮瘤心脏基底肿块在超声心动图上表现为离散肿块。未分化肉瘤是右心室肿块的病因。5 &lt;/del&gt;只狗中有 3 只的感染性心包炎是由继发性细菌感染的异物（即狐尾锥）引起的。&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;肿瘤是大多数 （76/107 [71%]） 狗心包积液的原因。15 只患有间皮瘤的狗中有 5 只患有离散的心脏肿块，最常见的是心脏底部 （4/5），很少是右心房 （1/5）。大多数 （35/40 [88%]） 右心房肿块为血管肉瘤，其次是神经内分泌肿瘤、甲状腺腺癌、间皮瘤、淋巴瘤和肉瘤各 1 例 （3%）。心脏基底肿块最常见的是神经内分泌肿瘤（9/23 [39.1%]狗），其次是甲状腺腺癌（6/23 [26.1%]）、间皮瘤（5/23 [21.7%]）和血管肉瘤（3/23 [13%]&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;）。'''间皮瘤心脏基底肿块'''在超声心动图上表现为'''离散肿块'''。未分化肉瘤是右心室肿块的病因。5 &lt;/ins&gt;只狗中有 3 只的感染性心包炎是由继发性细菌感染的异物（即狐尾锥）引起的。&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Neoplasia was the cause of pericardial effusion in a majority (76/107 [71%]) of dogs. Five of 15 dogs with mesothelioma had discrete cardiac masses, most often of the heart base (4/5) and rarely of the right atrium (1/5). A majority (35/40 [88%]) of right atrial masses were hemangiosarcoma, followed by 1 (3%) each of neuroendocrine tumor, thyroid gland adenocarcinoma, mesothelioma, lymphoma, and sarcoma. Heart base masses were most often neuroendocrine tumors (9/23 [39.1%] dogs), followed by thyroid gland adenocarcinoma (6/23 [26.1%]), mesothelioma (5/23 [21.7%]), and hemangiosarcoma (3/23 [13%]). Mesothelioma heart base masses were apparent as discrete masses on echocardiography. An undifferentiated sarcoma was the cause of the right ventricular mass. Infective pericarditis in 3 of 5 dogs was caused by foreign bodies (ie, foxtail awns) with secondary bacterial infections.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Neoplasia was the cause of pericardial effusion in a majority (76/107 [71%]) of dogs. Five of 15 dogs with mesothelioma had discrete cardiac masses, most often of the heart base (4/5) and rarely of the right atrium (1/5). A majority (35/40 [88%]) of right atrial masses were hemangiosarcoma, followed by 1 (3%) each of neuroendocrine tumor, thyroid gland adenocarcinoma, mesothelioma, lymphoma, and sarcoma. Heart base masses were most often neuroendocrine tumors (9/23 [39.1%] dogs), followed by thyroid gland adenocarcinoma (6/23 [26.1%]), mesothelioma (5/23 [21.7%]), and hemangiosarcoma (3/23 [13%]). Mesothelioma heart base masses were apparent as discrete masses on echocardiography. An undifferentiated sarcoma was the cause of the right ventricular mass. Infective pericarditis in 3 of 5 dogs was caused by foreign bodies (ie, foxtail awns) with secondary bacterial infections.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第123行：&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第123行：&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;在一些病例中，诊断结果不一致是显而易见的。根据心包液的细胞学分析，一只患有特发性心包炎的狗被归类为间皮瘤。一只患有化疗瘤的狗有脓性心包积液。放线菌属是从患有组织学证实的间皮瘤的狗中培养的。心包组织学检查错误地识别出 &lt;/del&gt;1 只患有间皮瘤的狗，该犬患有特发性心包炎和心外膜炎，在对第二次心包切除术期间获得的样本进行组织学检查时以及此后不久的尸检中发现。&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;在一些病例中，诊断结果不一致是显而易见的。根据心包液的细胞学分析，一只患有特发性心包炎的狗被归类为间皮瘤。一只患有化学感受器瘤的狗有脓性心包积液。放线菌属是从患有组织学证实的间皮瘤的狗中培养的。心包组织学检查错误地识别出 &lt;/ins&gt;1 只患有间皮瘤的狗，该犬患有特发性心包炎和心外膜炎，在对第二次心包切除术期间获得的样本进行组织学检查时以及此后不久的尸检中发现。&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Discordant diagnostic results were evident in several instances. One dog with idiopathic pericarditis was classified with a mesothelioma on the basis of cytologic analysis of pericardial fluid. One dog with a chemodectoma had purulent pericardial effusion. Actinomyces spp were cultured from a dog with histologically confirmed mesothelioma. Histologic examination of the pericardium incorrectly identified 1 dog with mesothelioma that had idiopathic pericarditis and epicarditis identified 2 years later during histologic examination of samples obtained during a second pericardectomy as well as during necropsy shortly thereafter.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Discordant diagnostic results were evident in several instances. One dog with idiopathic pericarditis was classified with a mesothelioma on the basis of cytologic analysis of pericardial fluid. One dog with a chemodectoma had purulent pericardial effusion. Actinomyces spp were cultured from a dog with histologically confirmed mesothelioma. Histologic examination of the pericardium incorrectly identified 1 dog with mesothelioma that had idiopathic pericarditis and epicarditis identified 2 years later during histologic examination of samples obtained during a second pericardectomy as well as during necropsy shortly thereafter.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;血液学和血清生化分析结果可用于 90 &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;只心包积液犬的审查。贫血是检测到的最常见的异常（23&lt;/del&gt;/90 [25.6%] 犬）。所有狗的贫血均为轻度（PCV，30%-37%）、色素正常、细胞正常且不可再生，但 2 只狗的 PCV &amp;lt; 30% 除外。在任何狗中均未检测到形态学红细胞异常。贫血最常见于患有血管肉瘤 （n = 8 只狗）、心包炎 （6） 和间皮瘤 （4） 的狗。90 只狗中有 21 只 （23.3%） &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;检测到肝酶活性增加;这些增长都被认为是温和的。在患有血管肉瘤 &lt;/del&gt;（n = &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;9）、化疗瘤 &lt;/del&gt;（5）、心包炎 （4）、不明确的心脏基底肿块 （2） 和甲状腺腺癌 （1） &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;的狗中检测到肝酶的高活性。血小板减少症（&lt;/del&gt;&amp;lt; 200,000 个血小板/μL）是第三大最常见的实验室异常，在 90 只狗中有 12 只 （13.3%） 发现。在患有血管肉瘤 （n = 6）、心包炎 （4） 和淋巴肉瘤 （2） 的狗中检测到血小板减少症。其他不常见的异常包括轻度氮质血症（4/90 &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;只狗）;凝血酶原时间、部分凝血活酶时间或两者轻微延长 （3）;轻度高钙血症（3）;和轻度高钾血症 （2）。在具有 &lt;/del&gt;3 &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;种最常检测到的血液学或生化异常（贫血、肝酶活性高或血小板减少症）的狗中，心包积液的最常见原因是血管肉瘤。&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;血液学和血清生化分析结果可用于 90 &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;只心包积液犬的审查。'''贫血'''是检测到的最常见的异常（23&lt;/ins&gt;/90 [25.6%] 犬）。所有狗的贫血均为轻度（PCV，30%-37%）、色素正常、细胞正常且不可再生，但 2 只狗的 PCV &amp;lt; 30% 除外。在任何狗中均未检测到形态学红细胞异常。贫血最常见于患有血管肉瘤 （n = 8 只狗）、心包炎 （6） 和间皮瘤 （4） 的狗。90 只狗中有 21 只 （23.3%） &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;检测到肝酶活性增加；这些增长都被认为是温和的。在患有血管肉瘤 &lt;/ins&gt;（n = &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;9）、化学感受器瘤 &lt;/ins&gt;（5）、心包炎 （4）、不明确的心脏基底肿块 （2） 和甲状腺腺癌 （1） &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;的狗中'''检测到肝酶的高活性'''。血'''小板减少'''症（&lt;/ins&gt;&amp;lt; 200,000 个血小板/μL）是第三大最常见的实验室异常，在 90 只狗中有 12 只 （13.3%） 发现。在患有血管肉瘤 （n = 6）、心包炎 （4） 和淋巴肉瘤 （2） 的狗中检测到血小板减少症。其他不常见的异常包括轻度氮质血症（4/90 &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;只狗），凝血酶原时间、部分凝血活酶时间或两者轻微延长 （3），轻度高钙血症（3），和轻度高钾血症 （2）。在'''具有 &lt;/ins&gt;3 &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;种最常检测到的血液学或生化异常（贫血、肝酶活性高或血小板减少症）的狗中，心包积液的最常见原因是血管肉瘤'''。&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Results of hematologic and serum biochemical analysis were available for review in 90 dogs with pericardial effusion. Anemia was the most common abnormality detected (23/90 [25.6%] dogs). Anemia was mild (PCV, 30% to 37%), normochromic, normocytic, and nonregenerative in all dogs, except for 2 in which the PCV was &amp;lt; 30%. Morphological RBC abnormalities were not detected in any of the dogs. Anemia was most commonly detected in dogs with hemangiosarcoma (n = 8 dogs), pericarditis (6), and mesothelioma (4). Increases in activities of liver enzymes were detected in 21 of 90 (23.3%) dogs; those increases were all considered mild. High activities of liver enzymes were detected in dogs with hemangiosarcoma (n = 9), chemodectoma (5), pericarditis (4), nondefined heart base masses (2), and thyroid gland adenocarcinoma (1). Thrombocytopenia (&amp;lt; 200,000 platelets/μL) was the third most common laboratory abnormality evident and was found in 12 of 90 (13.3%) dogs. Thrombocytopenia was detected in dogs with hemangiosarcoma (n = 6), pericarditis (4), and lymphosarcoma (2). Other uncommon abnormalities included mild azotemia (4/90 dogs); slight prolongation of the prothrombin time, partial thromboplastin time, or both (3); mild hypercalcemia (3); and mild hyperkalemia (2). In dogs with the 3 most commonly detected hematologic or biochemical abnormalities (anemia, high activities of liver enzymes, or thrombocytopenia), the most common cause of pericardial effusion was hemangiosarcoma.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Results of hematologic and serum biochemical analysis were available for review in 90 dogs with pericardial effusion. Anemia was the most common abnormality detected (23/90 [25.6%] dogs). Anemia was mild (PCV, 30% to 37%), normochromic, normocytic, and nonregenerative in all dogs, except for 2 in which the PCV was &amp;lt; 30%. Morphological RBC abnormalities were not detected in any of the dogs. Anemia was most commonly detected in dogs with hemangiosarcoma (n = 8 dogs), pericarditis (6), and mesothelioma (4). Increases in activities of liver enzymes were detected in 21 of 90 (23.3%) dogs; those increases were all considered mild. High activities of liver enzymes were detected in dogs with hemangiosarcoma (n = 9), chemodectoma (5), pericarditis (4), nondefined heart base masses (2), and thyroid gland adenocarcinoma (1). Thrombocytopenia (&amp;lt; 200,000 platelets/μL) was the third most common laboratory abnormality evident and was found in 12 of 90 (13.3%) dogs. Thrombocytopenia was detected in dogs with hemangiosarcoma (n = 6), pericarditis (4), and lymphosarcoma (2). Other uncommon abnormalities included mild azotemia (4/90 dogs); slight prolongation of the prothrombin time, partial thromboplastin time, or both (3); mild hypercalcemia (3); and mild hyperkalemia (2). In dogs with the 3 most commonly detected hematologic or biochemical abnormalities (anemia, high activities of liver enzymes, or thrombocytopenia), the most common cause of pericardial effusion was hemangiosarcoma.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Comcat</name></author>	</entry>

	<entry>
		<id>http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17118&amp;oldid=prev</id>
		<title>Comcat：/* 结论 */</title>
		<link rel="alternate" type="text/html" href="http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17118&amp;oldid=prev"/>
				<updated>2024-07-12T02:20:48Z</updated>
		
		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;结论&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class='diff diff-contentalign-left'&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
			&lt;tr valign='top'&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←上一版本&lt;/td&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;2024年7月12日 (五) 02:20的版本&lt;/td&gt;
			&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第113行：&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第113行：&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;在 107 只狗中分析了 47 只心包积液。液体分析确定了 47 只狗中有 6 只 （12.8%） 心包积液的原因，其中包括 5 只患有感染性心包炎的狗和 1 &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;只患有淋巴瘤的狗。大多数心包积液分为出血性积液（40&lt;/del&gt;/47 [85%]犬），其次是化脓性炎症（6/47 [12.8%]）、化脓性肉芽肿性炎症（4/47 [8.5%]）、改良渗出液（2/47 [4.3%]）和乳糜性积液（1/47 [2.1%]）。47 只狗中有 25 只 （53.2%） 发现了间皮反应性。在 1 只患有淋巴瘤、间皮瘤和特发性心包炎的狗中发现了肿瘤细胞。&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;在 107 只狗中分析了 47 只心包积液。液体分析确定了 47 只狗中有 6 只 （12.8%） 心包积液的原因，其中包括 5 只患有感染性心包炎的狗和 1 &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;只患有淋巴瘤的狗。'''大多数心包积液分为出血性积液'''（40&lt;/ins&gt;/47 [85%]犬），其次是化脓性炎症（6/47 [12.8%]）、化脓性肉芽肿性炎症（4/47 [8.5%]）、改良渗出液（2/47 [4.3%]）和乳糜性积液（1/47 [2.1%]）。47 只狗中有 25 只 （53.2%） 发现了间皮反应性。在 1 只患有淋巴瘤、间皮瘤和特发性心包炎的狗中发现了肿瘤细胞。&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Pericardial effusion was analyzed in 47 of 107 dogs. Fluid analysis identified the cause of the pericardial effusion in 6 of 47 (12.8%) dogs, which included 5 dogs with infective pericarditis and 1 dog with lymphoma. Most pericardial effusion was classified as hemorrhagic fluid (40/47 [85%] dogs), followed by suppurative inflammation (6/47 [12.8%]), pyogranulomatous inflammation (4/47 [8.5%]), a modified transudate (2/47 [4.3%]), and chylous effusion (1/47 [2.1%]). Mesothelial reactivity was identified in 25 of 47 (53.2%) dogs. Neoplastic cells were identified in 1 dog each with lymphoma, mesothelioma, and idiopathic pericarditis.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Pericardial effusion was analyzed in 47 of 107 dogs. Fluid analysis identified the cause of the pericardial effusion in 6 of 47 (12.8%) dogs, which included 5 dogs with infective pericarditis and 1 dog with lymphoma. Most pericardial effusion was classified as hemorrhagic fluid (40/47 [85%] dogs), followed by suppurative inflammation (6/47 [12.8%]), pyogranulomatous inflammation (4/47 [8.5%]), a modified transudate (2/47 [4.3%]), and chylous effusion (1/47 [2.1%]). Mesothelial reactivity was identified in 25 of 47 (53.2%) dogs. Neoplastic cells were identified in 1 dog each with lymphoma, mesothelioma, and idiopathic pericarditis.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Comcat</name></author>	</entry>

	<entry>
		<id>http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17117&amp;oldid=prev</id>
		<title>Comcat：/* 结论 */</title>
		<link rel="alternate" type="text/html" href="http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17117&amp;oldid=prev"/>
				<updated>2024-07-12T02:19:32Z</updated>
		
		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;结论&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class='diff diff-contentalign-left'&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
			&lt;tr valign='top'&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←上一版本&lt;/td&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;2024年7月12日 (五) 02:19的版本&lt;/td&gt;
			&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第103行：&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第103行：&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;67 只 （62.6%） 心包积液的狗有右心衰竭的证据。大多数狗 （36/107 [33.6%]） 并发胸腔积液和腹水，少数狗出现孤立性腹水 （17/107 [15.9%]） 或胸腔积液 （14/107 [13.1%]）。双腔积液（P=1.00）、胸腔积液（P=0.84）或腹水（P=0.93）的肿瘤性和非肿瘤性病因之间没有差异。根据 107 只狗中有 42 只 （39%） &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;的超声心动图结果，主观怀疑心包填塞。在检查胸 &lt;/del&gt;X &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;光片时，107 &lt;/del&gt;只狗中有 56 只 （52.3%） &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;发现了球形心脏，这对检测心包积液的敏感性较差。在尸检或心包切除术中确认肺转移的 &lt;/del&gt;21 只狗中有 7 只 （33.3%） 在检查胸 X 线片时才发现肺转移。在对 63 只有肿块的狗中的 10 只进行胸 X 线片检查时，怀疑右心房或心脏基底肿块，特异性为 100%。&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;67 只 （62.6%） 心包积液的狗有右心衰竭的证据。大多数狗 （36/107 [33.6%]） 并发胸腔积液和腹水，少数狗出现孤立性腹水 （17/107 [15.9%]） 或胸腔积液 （14/107 [13.1%]）。双腔积液（P=1.00）、胸腔积液（P=0.84）或腹水（P=0.93）的肿瘤性和非肿瘤性病因之间没有差异。根据 107 只狗中有 42 只 （39%） &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;的超声心动图结果，主观怀疑心包填塞。在检查'''胸 &lt;/ins&gt;X &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;光片'''时，107 &lt;/ins&gt;只狗中有 56 只 （52.3%） &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;发现了'''球形心脏'''，这'''对检测心包积液的敏感性较差'''。在尸检或心包切除术中确认肺转移的 &lt;/ins&gt;21 只狗中有 7 只 （33.3%） 在检查胸 X 线片时才发现肺转移。在对 63 只有肿块的狗中的 10 只进行胸 X 线片检查时，怀疑右心房或心脏基底肿块，特异性为 100%。&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Sixty-seven (62.6%) dogs with pericardial effusion had evidence of right-sided heart failure. Most dogs (36/107 [33.6%]) had concurrent pleural effusion and ascites, with fewer dogs with isolated ascites (17/107 [15.9%]) or pleural effusion (14/107 [13.1%]). There was no difference between neoplastic and nonneoplastic causes for bicavitary effusion (P = 1.00), pleural effusion (P = 0.84), or ascites (P = 0.93). Cardiac tamponade was subjectively suspected on the basis of results of echocardiography in 42 of 107 (39%) dogs. A globoid-shaped heart was identified in 56 of 107 (52.3%) dogs during examination of thoracic radiographs, which yielded a poor sensitivity for detection of pericardial effusion. Pulmonary metastases were only identified during examination of thoracic radiographs in 7 of 21 (33.3%) dogs with confirmed pulmonary metastases during necropsy or pericardectomy. There was a suspicion of a right atrial or heart base mass during examination of thoracic radiographs in 10 of 63 dogs with masses, with a specificity of 100%.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Sixty-seven (62.6%) dogs with pericardial effusion had evidence of right-sided heart failure. Most dogs (36/107 [33.6%]) had concurrent pleural effusion and ascites, with fewer dogs with isolated ascites (17/107 [15.9%]) or pleural effusion (14/107 [13.1%]). There was no difference between neoplastic and nonneoplastic causes for bicavitary effusion (P = 1.00), pleural effusion (P = 0.84), or ascites (P = 0.93). Cardiac tamponade was subjectively suspected on the basis of results of echocardiography in 42 of 107 (39%) dogs. A globoid-shaped heart was identified in 56 of 107 (52.3%) dogs during examination of thoracic radiographs, which yielded a poor sensitivity for detection of pericardial effusion. Pulmonary metastases were only identified during examination of thoracic radiographs in 7 of 21 (33.3%) dogs with confirmed pulmonary metastases during necropsy or pericardectomy. There was a suspicion of a right atrial or heart base mass during examination of thoracic radiographs in 10 of 63 dogs with masses, with a specificity of 100%.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Comcat</name></author>	</entry>

	<entry>
		<id>http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17116&amp;oldid=prev</id>
		<title>Comcat：/* 结论 */</title>
		<link rel="alternate" type="text/html" href="http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17116&amp;oldid=prev"/>
				<updated>2024-07-12T02:18:08Z</updated>
		
		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;结论&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class='diff diff-contentalign-left'&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
			&lt;tr valign='top'&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←上一版本&lt;/td&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;2024年7月12日 (五) 02:18的版本&lt;/td&gt;
			&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第98行：&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第98行：&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;大多数患有心包积液的狗是大型犬;体重范围为 &lt;/del&gt;3.6 至 73.0 公斤（7.9 至 160.6 磅），中位数为 31.5 公斤（69.3 &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;磅）。最常见的品种包括金毛猎犬（20&lt;/del&gt;/107 [18.7%]&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;）、拉布拉多猎犬（16&lt;/del&gt;/107 [14.9%]&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;）和德国牧羊犬（5&lt;/del&gt;/107 [4.7%]）。有心脏肿块的狗（平均 9.7 岁）比没有肿块的狗（平均 7.9 岁）明显 （P = 0.006）。&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;大多数患有'''心包积液'''的狗是大型犬：体重范围为 &lt;/ins&gt;3.6 至 73.0 公斤（7.9 至 160.6 磅），中位数为 31.5 公斤（69.3 &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;磅）。'''最常见的品种'''包括'''金毛'''猎犬（20&lt;/ins&gt;/107 [18.7%]&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;）、'''拉布拉多'''猎犬（16&lt;/ins&gt;/107 [14.9%]&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;）和'''德国牧'''羊犬（5&lt;/ins&gt;/107 [4.7%]）。有心脏肿块的狗（平均 9.7 岁）比没有肿块的狗（平均 7.9 岁）明显 （P = 0.006）。&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Most dogs with pericardial effusion were largebreed dogs; body weight ranged from 3.6 to 73.0 kg (7.9 to 160.6 lb), with a median of 31.5 kg (69.3 lb). The most common breeds included Golden Retriever (20/107 [18.7%] dogs), Labrador Retriever (16/107 [14.9%]), and German Shepherd Dog (5/107 [4.7%]). Dogs with cardiac masses were significantly (P = 0.006) older (mean, 9.7 years) than dogs without masses (mean, 7.9 years).&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Most dogs with pericardial effusion were largebreed dogs; body weight ranged from 3.6 to 73.0 kg (7.9 to 160.6 lb), with a median of 31.5 kg (69.3 lb). The most common breeds included Golden Retriever (20/107 [18.7%] dogs), Labrador Retriever (16/107 [14.9%]), and German Shepherd Dog (5/107 [4.7%]). Dogs with cardiac masses were significantly (P = 0.006) older (mean, 9.7 years) than dogs without masses (mean, 7.9 years).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Comcat</name></author>	</entry>

	<entry>
		<id>http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17115&amp;oldid=prev</id>
		<title>Comcat：/* 结论 */</title>
		<link rel="alternate" type="text/html" href="http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17115&amp;oldid=prev"/>
				<updated>2024-07-12T02:16:33Z</updated>
		
		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;结论&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class='diff diff-contentalign-left'&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
			&lt;tr valign='top'&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←上一版本&lt;/td&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;2024年7月12日 (五) 02:16的版本&lt;/td&gt;
			&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第93行：&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第93行：&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;对 59 只狗进行了完全尸检（仅尸检 44 次，心包切除术和尸检 15 次）。患有血管肉瘤（19/28 [67.9%]）、间皮瘤（5/9 [55.6%]）、甲状腺腺癌（2/3 [66.7%]&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;）或化疗瘤（4&lt;/del&gt;/6 [66.7%]）的狗之间的转移率无显著差异（P = 1.00）。28 只患有心源性血管肉瘤的狗中有 8 只 （28.6%） 也患有脾脏血管肉瘤。所有患有淋巴瘤的狗都有转移性疾病。所有肿瘤犬最常见的转移部位是肺（18/59 [30.5%]&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;）。在患有心脏血管肉瘤的狗中，最常见的转移部位包括肺 &lt;/del&gt;（12/28 [42.9%]&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;）、脾脏 &lt;/del&gt;（8/28 [28.6%]）、肝脏 （8/28 [28.6%]） 和肾脏 （4/28 [14.3%]）。患有间皮瘤的狗最常见的转移部位包括胸内淋巴结 （6/9 [66.7%]）、肺 （2/9 [22.2%]） 和胸膜 （2/9 [22.2%]）。在患有神经内分泌肿瘤的狗中，最常见的转移部位是肺（3/6 [50%]），其次是脾脏（1/6 [16.7%]）和肝脏（1/6 [16.7%]）。患有甲状腺腺癌的狗最常见的转移部位是心包（2/3 [66.7%]），其次是肺转移（1/3 [33.3%]）和心肌转移（1/3 [33.3%]）和经腔血转移（1/3 [33.3%]）。&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;对 59 只狗进行了完全尸检（仅尸检 44 次，心包切除术和尸检 15 次）。患有血管肉瘤（19/28 [67.9%]）、间皮瘤（5/9 [55.6%]）、甲状腺腺癌（2/3 [66.7%]&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;）或化学感受器瘤（4&lt;/ins&gt;/6 [66.7%]）的狗之间的转移率无显著差异（P = 1.00）。28 只患有心源性血管肉瘤的狗中有 8 只 （28.6%） 也患有脾脏血管肉瘤。所有患有淋巴瘤的狗都有转移性疾病。所有肿瘤犬最常见的转移部位是肺（18/59 [30.5%]&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;）。在'''患有心脏血管肉瘤'''的狗中，'''最常见的转移部位'''包括'''肺''' &lt;/ins&gt;（12/28 [42.9%]&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;）、'''脾脏''' &lt;/ins&gt;（8/28 [28.6%]）、肝脏 （8/28 [28.6%]） 和肾脏 （4/28 [14.3%]）。患有间皮瘤的狗最常见的转移部位包括胸内淋巴结 （6/9 [66.7%]）、肺 （2/9 [22.2%]） 和胸膜 （2/9 [22.2%]）。在患有神经内分泌肿瘤的狗中，最常见的转移部位是肺（3/6 [50%]），其次是脾脏（1/6 [16.7%]）和肝脏（1/6 [16.7%]）。患有甲状腺腺癌的狗最常见的转移部位是心包（2/3 [66.7%]），其次是肺转移（1/3 [33.3%]）和心肌转移（1/3 [33.3%]）和经腔血转移（1/3 [33.3%]）。&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Complete necropsy was performed on 59 dogs (44 necropsy alone and 15 pericardectomy and necropsy). The metastatic rate did not differ significantly (P = 1.00 for all comparisons) between dogs with hemangiosarcoma (19/28 [67.9%]), mesothelioma (5/9 [55.6%]), thyroid gland adenocarcinoma (2/3 [66.7%]), or chemodectoma (4/6 [66.7%]). Eight of 28 (28.6%) dogs with cardiac hemangiosarcoma also had splenic hemangiosarcoma. All dogs with lymphoma had metastatic disease. The most common site of metastasis for all neoplastic dogs was the lungs (18/59 [30.5%]). In dogs with cardiac hemangiosarcoma, the most common sites of metastasis included the lungs (12/28 [42.9%]), spleen (8/28 [28.6%]), liver (8/28 [28.6%]), and kidneys (4/28 [14.3%]). The most common sites of metastasis in dogs with mesothelioma included the intrathoracic lymph nodes (6/9 [66.7%]), lungs (2/9 [22.2%]), and pleurae (2/9 [22.2%]). In dogs with neuroendocrine tumors, the most common site of metastasis was the lungs (3/6 [50%]), followed by the spleen (1/6 [16.7%]) and liver (1/6 [16.7%]). The most common site of metastasis for dogs with thyroid gland adenocarcinoma was the pericardium (2/3 [66.7%]), followed by metastasis to the lungs (1/3 [33.3%]) and myocardium (1/3 [33.3%]) and transcoelomic metastasis (1/3 [33.3%]).&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Complete necropsy was performed on 59 dogs (44 necropsy alone and 15 pericardectomy and necropsy). The metastatic rate did not differ significantly (P = 1.00 for all comparisons) between dogs with hemangiosarcoma (19/28 [67.9%]), mesothelioma (5/9 [55.6%]), thyroid gland adenocarcinoma (2/3 [66.7%]), or chemodectoma (4/6 [66.7%]). Eight of 28 (28.6%) dogs with cardiac hemangiosarcoma also had splenic hemangiosarcoma. All dogs with lymphoma had metastatic disease. The most common site of metastasis for all neoplastic dogs was the lungs (18/59 [30.5%]). In dogs with cardiac hemangiosarcoma, the most common sites of metastasis included the lungs (12/28 [42.9%]), spleen (8/28 [28.6%]), liver (8/28 [28.6%]), and kidneys (4/28 [14.3%]). The most common sites of metastasis in dogs with mesothelioma included the intrathoracic lymph nodes (6/9 [66.7%]), lungs (2/9 [22.2%]), and pleurae (2/9 [22.2%]). In dogs with neuroendocrine tumors, the most common site of metastasis was the lungs (3/6 [50%]), followed by the spleen (1/6 [16.7%]) and liver (1/6 [16.7%]). The most common site of metastasis for dogs with thyroid gland adenocarcinoma was the pericardium (2/3 [66.7%]), followed by metastasis to the lungs (1/3 [33.3%]) and myocardium (1/3 [33.3%]) and transcoelomic metastasis (1/3 [33.3%]).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Comcat</name></author>	</entry>

	<entry>
		<id>http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17114&amp;oldid=prev</id>
		<title>2024年7月12日 (五) 02:10 Comcat</title>
		<link rel="alternate" type="text/html" href="http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17114&amp;oldid=prev"/>
				<updated>2024-07-12T02:10:53Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class='diff diff-contentalign-left'&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
			&lt;tr valign='top'&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←上一版本&lt;/td&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;2024年7月12日 (五) 02:10的版本&lt;/td&gt;
			&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第1行：&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第1行：&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Echocardiographic and clinicopathologic characterization of pericardial effusion in dogs: 107 cases (1985–2006)&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== 摘要 ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== 摘要 ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Comcat</name></author>	</entry>

	<entry>
		<id>http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17110&amp;oldid=prev</id>
		<title>Comcat：/* References */</title>
		<link rel="alternate" type="text/html" href="http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%BF%83%E5%8C%85%E7%A7%AF%E6%B6%B2%E7%9A%84%E8%B6%85%E5%A3%B0%E5%BF%83%E5%8A%A8%E5%9B%BE%E5%92%8C%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E5%AD%A6%E7%89%B9%E5%BE%81%EF%BC%9A107_%E4%BE%8B_%EF%BC%881985%E2%80%932006%EF%BC%89&amp;diff=17110&amp;oldid=prev"/>
				<updated>2024-07-11T23:39:14Z</updated>
		
		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;References&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class='diff diff-contentalign-left'&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
			&lt;tr valign='top'&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←上一版本&lt;/td&gt;
			&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;2024年7月11日 (四) 23:39的版本&lt;/td&gt;
			&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第215行：&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;第215行：&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[狗狗心包积液]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[狗狗心包积液]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;br&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Comcat</name></author>	</entry>

	</feed>